InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
22
T+90 hit rate
29%
T+90 mean return
+6.2%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Macias William L., Directeur Médical. Director active across 1 company, notably Immunovant, Inc.. Aggregated, 29 disclosures have been recorded. Split: 0 buy · 22 sells. Total volume traded: €1.5m. History available since 11 June 2021. The latest transaction was filed on 19 February 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations29 total
2,055 shares@ US$20.862.7% of flowCommon StockSEC:0001764013-25-000032:0
1,883 shares@ US$23.812.9% of flowCommon StockSEC:0001764013-25-000015:0
3,353 shares@ US$25.455.4% of flowCommon StockSEC:0001764013-24-000195:0
2,627 shares@ US$28.794.6% of flowCommon StockSEC:0001764013-24-000173:0
2,907 shares@ US$31.845.5% of flowCommon StockSEC:0001764013-24-000159:0
2,362 shares@ US$29.644.3% of flowCommon StockSEC:0001764013-24-000136:0
3,247 shares@ US$29.655.9% of flowCommon StockSEC:0001764013-24-000096:0
6,136 shares@ US$28.8011.0% of flowCommon StockSEC:0001764013-24-000081:0
54,978 shares0Common StockSEC:0001764013-24-000053:0
2,221 shares@ US$36.154.9% of flowCommon StockSEC:0001764013-24-000039:0
424 shares@ US$41.031.1% of flowCommon StockSEC:0001764013-24-000014:0
3,141 shares@ US$32.756.3% of flowCommon StockSEC:0001764013-23-000139:0
530 shares@ US$36.801.2% of flowCommon StockSEC:0001764013-23-000122:0
12,332 shares@ US$20.3015.4% of flowCommon StockSEC:0001764013-23-000099:0
426 shares@ US$24.940.6% of flowCommon StockSEC:0001764013-23-000082:0
509 shares@ US$16.290.5% of flowCommon StockSEC:0001764013-23-000061:0
87,664 shares0Common StockSEC:0001764013-23-000039:0
537 shares@ US$18.240.6% of flowCommon StockSEC:0001764013-23-000024:0
120 shares@ US$15.110.1% of flowCommon StockSEC:0001764013-23-000006:0
341 shares@ US$9.670.2% of flowCommon StockSEC:0001764013-22-000134:0
112,816 shares0Common StockSEC:0001764013-22-000105:0
322 shares@ US$4.700.1% of flowCommon StockSEC:0001764013-22-000074:0
1,392 shares@ US$4.980.0001% mcap1.6% of flowCommon StockSEC:0001764013-22-000039:0
26,813 shares@ US$8.280.0035% mcap49.2% of flowCommon StockSEC:0001764013-22-000004:0
26,813 shares@ US$8.2813.1% of flowCommon StockSEC:0001764013-22-000004
25 of 29 declarations
About Macias William L.
Macias William L. is the Chief Medical Officer of Immunovant, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is crucial for the development of new treatments and ensuring compliance with medical regulations. William brings significant expertise in the medical field, contributing to Immunovant, Inc.'s mission to provide innovative solutions.
